CLEAN AIR ACT OZONE-DEPLETING SUBSTANCE BANS: INTERIM EXEMPTIONS
This article was originally published in The Gray Sheet
Executive Summary
CLEAN AIR ACT OZONE-DEPLETING SUBSTANCE BANS: INTERIM EXEMPTIONS for "potentially essential" medical products are available, FDA says in a notice published in the Dec. 28 Federal Register. "Because of the impending effective dates" of bans on the sale or distribution of certain "nonessential" products that either release a class I ozone-depleting substance into the environment or contain a class II ozone-depleting substance, FDA says it will "consider granting" interim exemptions "based on the filing of a petition" requesting "essential" status for a product.